The Cooper Companies, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2024
May 31, 2024 at 01:45 am IST
Share
The Cooper Companies, Inc. reported earnings results for the second quarter and six months ended April 30, 2024. For the second quarter, the company reported sales was USD 942.6 million compared to USD 877.4 million a year ago. Net income was USD 88.9 million compared to USD 39.8 million a year ago. Diluted earnings per share from continuing operations was USD 0.44 compared to USD 0.2 a year ago.
For the six months, sales was USD 1,874.2 million compared to USD 1,735.9 million a year ago. Net income was USD 170.1 million compared to USD 124.4 million a year ago. Diluted earnings per share from continuing operations was USD 0.85 compared to USD 0.63 a year ago.
The Cooper Companies, Inc. is a global medical device company. The Company operates through two business units: CooperVision and CooperSurgical. CooperVision is engaged in the contact lens industry. CooperVisionâs products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys, Biofinity toric & Biofinity XR toric, Biofinity multifocal, Biofinity toric multifocal, clariti 1 day, clariti 1 day toric, clariti 1 day multifocal, MiSight 1 day, Avaira Vitality and Avaira Vitality toric. CooperSurgical is a fertility and womenâs health company dedicated to assisting women, babies and families around the world. CooperSurgical provides a range of products and services with an emphasis on improving fertility solutions, empowering office-based care, and advancing hospital care within womenâs health. CooperSurgicalâs brands include Paragard, ER-Complete, Fetal Pillow, INSORB, PGT-Complete, RUMI II and others.
THE COOPER COMPANIES, INC. 
